Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Public ClinicalTrials.gov record NCT07482176. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-masked, Active-comparator-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Study identification
- NCT ID
- NCT07482176
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Adverum Biotechnologies, Inc.
- Industry
- Enrollment
- 284 participants
Conditions and interventions
Interventions
- Aflibercept Drug
- Ixo-vec Genetic
Drug · Genetic
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 15, 2026
- Primary completion
- Nov 14, 2027
- Completion
- Oct 19, 2031
- Last update posted
- May 19, 2026
2026 – 2031
United States locations
- U.S. sites
- 46
- U.S. states
- 15
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Adverum Clinical Site 126 | Phoenix | Arizona | 85014 | Recruiting |
| Adverum Clinical Site 178 | Phoenix | Arizona | 85020 | Recruiting |
| Adverum Clinical Site 223 | Phoenix | Arizona | 85020 | Recruiting |
| Adverum Clinical Site 229 | Scottsdale | Arizona | 85255 | Recruiting |
| Adverum Clinical Site 198 | Springdale | Arkansas | 72764 | Recruiting |
| Adverum Clinical Site 109 | Bakersfield | California | 93309 | Recruiting |
| Adverum Clinical Site 100 | Beverly Hills | California | 90211 | Recruiting |
| Adverum Clinical Site 201 | Campbell | California | 95008 | Recruiting |
| Adverum Clinical Site 172 | Encino | California | 91436 | Recruiting |
| Adverum Clinical Site 169 | Fullerton | California | 92835 | Recruiting |
| Adverum Clinical Site 224 | Huntington Beach | California | 92647 | Recruiting |
| Adverum Clinical Site 215 | Redlands | California | 92374 | Recruiting |
| Adverum Clinical Site 140 | Sacramento | California | 95825 | Recruiting |
| Adverum Clinical Site 212 | Sacramento | California | 95841 | Recruiting |
| Adverum Clinical Site 202 | Torrance | California | 90503 | Recruiting |
| Adverum Clinical Site 189 | Walnut Creek | California | 94598 | Recruiting |
| Adverum Clinical Site 116 | Denver | Colorado | 80207 | Recruiting |
| Adverum Clinical Site 165 | Waterford | Connecticut | 06385 | Recruiting |
| Adverum Clinical Site 124 | Deerfield Beach | Florida | 33064 | Recruiting |
| Adverum Clinical Site 184 | Deerfield Beach | Florida | 33064 | Recruiting |
| Adverum Clinical Site 176 | Fort Lauderdale | Florida | 33308 | Recruiting |
| Adverum Clinical Site 221 | Fort Myers | Florida | 33912 | Recruiting |
| Adverum Clinical Site 214 | Lakeland | Florida | 33805 | Recruiting |
| Adverum Clinical Site 213 | Orlando | Florida | 32806 | Recruiting |
| Adverum Clinical Site 183 | South Miami | Florida | 33143 | Recruiting |
| Adverum Clinical Site 182 | Augusta | Georgia | 30909 | Recruiting |
| Adverum Clinical Site 195 | Carmel | Indiana | 46032 | Recruiting |
| Adverum Clinical Site 204 | Hagerstown | Maryland | 21740 | Recruiting |
| Adverum Clinical Site 216 | Jackson | Mississippi | 39202 | Recruiting |
| Adverum Clinical Site 225 | Liverpool | New York | 13088 | Recruiting |
| Adverum Clinical Site 196 | Asheville | North Carolina | 28803 | Recruiting |
| Adverum Clinical Site 211 | Greensboro | North Carolina | 27401 | Recruiting |
| Adverum Clinical Site 219 | Greensboro | North Carolina | 27401 | Recruiting |
| Adverum Clinical Site 220 | Hickory | North Carolina | 28602 | Recruiting |
| Adverum Clinical Site 209 | Wake Forest | North Carolina | 27587 | Recruiting |
| Adverum Clinical Site 241 | Bluffton | South Carolina | 29910 | Recruiting |
| Adverum Clinical Site 222 | Ladson | South Carolina | 29456 | Recruiting |
| Adverum Clinical Site 127 | Austin | Texas | 78705 | Recruiting |
| Adverum Clinical Site 107 | Conroe | Texas | 77384 | Recruiting |
| Adverum Clinical Site 194 | Dallas | Texas | 75231 | Recruiting |
| Adverum Clinical Site 162 | McAllen | Texas | 78503 | Recruiting |
| Adverum Clinical Site 232 | San Marcos | Texas | 78666 | Recruiting |
| Adverum Clinical Site 228 | Schertz | Texas | 78154 | Recruiting |
| Adverum Clinical Site 231 | The Woodlands | Texas | 77384 | Recruiting |
| Adverum Clinical Site 237 | Tyler | Texas | 75703 | Recruiting |
| Adverum Clinical Site 199 | Lynchburg | Virginia | 24502 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07482176, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 19, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07482176 live on ClinicalTrials.gov.